Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
AUUDW
14101
DELISTED
Auddia Inc Warrants
AUUDW
| $1.86K | ﹤0.01% |
74,592
+387
| +0.5% | +$11 |
2024 Q2
2 quarters
|
|
|
ELEV
14102
PUT
DELISTED
Elevation Oncology
ELEV
| $1.86K | ﹤0.01% |
3,300
-24,300
| -88% | -$14.3K |
2024 Q2
2 quarters
|
|
14103
Focus Universal
FCUV
$3.08M
| $1.85K | ﹤0.01% |
13
-143
| -92% | -$14.6K |
2024 Q3
1 quarter
|
|
14104
CALL
Hyperfine
HYPR
$94.8M
| $1.85K | ﹤0.01% |
2,100
+1,000
| +91% | +$962 |
2024 Q1
3 quarters
|
|
14105
CALL
TH International
THCH
$37.2M
| $1.85K | ﹤0.01% |
+520
| New | +$1.97K |
2024 Q4
0 quarters
|
|
14106
PUT
Savara
SVRA
$988M
| $1.84K | ﹤0.01% |
600
-11,700
| -95% | -$40.8K |
2024 Q1
3 quarters
|
|
14107
CALL
MeiraGTx Holdings
MGTX
$1.04B
| $1.83K | ﹤0.01% |
300
-18,900
| -98% | -$111K |
2021 Q4
12 quarters
|
|
|
KZR
14108
CALL
DELISTED
Kezar Life Sciences
KZR
| $1.81K | ﹤0.01% |
270
-1,110
| -80% | -$8.27K |
2021 Q4
12 quarters
|
|
14109
CALL
Inspired Entertainment
INSE
$91.2M
| $1.81K | ﹤0.01% |
200
-23,300
| -99% | -$221K |
2022 Q3
9 quarters
|
|
|
MAPS
14110
PUT
DELISTED
WM TECHNOLOGY INC A
MAPS
| $1.79K | ﹤0.01% |
1,300
-4,800
| -79% | -$5.16K |
2021 Q1
15 quarters
|
|
|
ATXS
14111
PUT
DELISTED
Astria Therapeutics
ATXS
| $1.79K | ﹤0.01% |
200
-3,100
| -94% | -$32.9K |
2022 Q4
8 quarters
|
|
14112
PUT
NRC Health Common Stock
NRC
$450M
| $1.76K | ﹤0.01% |
100
-200
| -67% | -$3.79K |
2024 Q2
2 quarters
|
|
14113
PUT
Achieve Life Sciences
ACHV
$746M
| $1.76K | ﹤0.01% |
500
-3,200
| -86% | -$14.5K |
2024 Q1
3 quarters
|
|
14114
Dragonfly Energy Holdings Warrant
DFLIW
$1.57K
| $1.71K | ﹤0.01% |
60,324
-269
| -0.4% | -$6 |
2024 Q1
3 quarters
|
|
14115
60 Degrees Pharmaceuticals Warrant
SXTPW
$40.7K
| $1.71K | ﹤0.01% |
47,675
+1,402
| +3% | +$41 |
2024 Q1
3 quarters
|
|
14116
CALL
Resources Connection
RGP
$134M
| $1.71K | ﹤0.01% |
200
-1,400
| -88% | -$11.8K |
2022 Q4
8 quarters
|
|
14117
CALL
Clene
CLNN
$58M
| $1.7K | ﹤0.01% |
+320
| New | +$1.61K |
2024 Q4
0 quarters
|
|
|
BRSP
14118
CALL
BrightSpire Capital
BRSP
$482M
| $1.69K | ﹤0.01% |
300
-300
| -50% | -$1.77K |
2021 Q2
14 quarters
|
|
14119
PUT
First Commonwealth Financial
FCF
$2.08B
| $1.69K | ﹤0.01% |
100
-4,600
| -98% | -$81.3K |
2023 Q1
7 quarters
|
|
14120
PUT
Intellicheck
IDN
$46M
| $1.68K | ﹤0.01% |
600
-500
| -45% | -$1.26K |
2024 Q2
2 quarters
|
|
14121
CALL
Key Tronic
KTCC
$25M
| $1.67K | ﹤0.01% |
400
-1,600
| -80% | -$8.68K |
2023 Q2
6 quarters
|
|
14122
CALL
Entravision Communication
EVC
$681M
| $1.65K | ﹤0.01% |
700
+400
| +133% | +$936 |
2024 Q3
1 quarter
|
|
14123
PUT
Clear Channel Outdoor Holdings
CCO
$1.22B
| $1.64K | ﹤0.01% |
+1,200
| New | +$1.83K |
2024 Q4
0 quarters
|
|
|
MMVWW
14124
DELISTED
MultiMetaVerse Holdings Limited Warrant
MMVWW
| $1.64K | ﹤0.01% |
67,922
-60,758
| -47% | -$2.05K |
2024 Q2
2 quarters
|
|
|
CYTHW
14125
DELISTED
Cyclo Therapeutics, Inc. Warrant
CYTHW
| $1.64K | ﹤0.01% |
11,693
+100
| +0.9% | +$16 |
2023 Q4
4 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.